Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 24 resultados

TOX-Free: TOXicity assessment on neurons and cardiomyocytes by means of FluoRescence Emitting Electrodes NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-FETOPEN-2018-2020 Pre- and post-marketing data on drug side effects show that neurotoxicity and cardiotoxicity are frequently missed or underestimated during...
2020-12-16 - 2024-11-30 | Financiado

ENTRAIN VISION: European Network for integrated TRAINing on Innovative Therapies for VISion RestoratiON NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-MSCA-ITN-2019 Blindness is the most feared handicap leading to the greatest exclusion from society by reducing patient autonomy and mobility. There are st...
2020-05-12 - 2024-09-30 | Financiado

CORESMA: COVID 19 Outbreak Response combining E health Serolomics Modelling Artificial Intelligence and Im... NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 Among the biggest challenges in the COVID-19 outbreak are the lack of triangulation of clinical, epidemiologic and immunological information...
2020-04-15 - 2023-12-31 | Financiado

BW-KAM 5: The Enterprise Europe Network Baden Wuerttemberg Targeting Innovation from Baden W rttemberg for... BW-KAM 5 will implement tested and tailored innovation management services and tools to enhance innovation management capacities in Baden-Wü...
2019-12-10 - 2021-12-31 | Financiado

iPSpine: Induced pluripotent stem cell based therapy for spinal regeneration NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-SC1-BHC-2018-2020 Low back pain (LBP) is a leading cause of disability and morbidity worldwide. It is widely accepted that a major contributor to LBP is inter...
2018-12-07 - 2024-06-30 | Financiado

BW-KAM 4: The Enterprise Europe Network Baden Wuerttemberg Targeting Innovation from Baden W rttemberg for E... BW-KAM 4 will implement tried, tested and tailored innovation management services to enhance innovation management capacities in Baden-Württ...
2018-11-30 - 2019-12-31 | Financiado

RESHAPE: Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next Generation regulatory T ce... NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-SC1-BHC-2018-2020 Adoptive transfer of regulatory T cells (Treg) is a promising new therapeutic option to reshape undesired intra-tissue immune imbalance in i...
2018-11-21 - 2024-12-31 | Financiado

EUROoC: Interdisciplinary training network for advancing Organ on a chip technology in Europe NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN tramitó un H2020: H2020-MSCA-ITN-2018 EUROoC will create a trans-European network of industrially oriented specialists fully trained in development and application of the emergin...
2018-08-21 - 2023-05-31 | Financiado

BonePainII: A European Training Network to Combat Bone Pain NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-MSCA-ITN-2018 In Europe 20 - 30% of adults are affected at any one time by musculoskeletal pain such as arthritic pain, lower back pain, pain from osteopo...
2018-08-20 - 2022-12-31 | Financiado

BW-KAM3: The Enterprise Europe Network Baden Wuerttemberg Feeding the Innovation Pipeline in Baden Wuerttem... By providing Key Account Management and Enhanced Innovation Management Capacity services, the overall objective of the BW-KAM3 project is to...
2017-04-28 - 2018-12-31 | Financiado

NGN-PET: Modelling Neuron Glia Networks into a drug discovery platform for Pain Efficacious Treatments Sofi... NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-JTI-IMI2-2015-07-two-stage Chronic Neuropathic Pain is frequently associated with peripheral nerve injury or disease. Peripheral injury activates both neuronal and gli...
2017-04-26 - 2020-03-31 | Financiado

switchBoard: In the eye of the observer Visual processing at the heart of the retina NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un H2020: H2020-MSCA-ITN-2015 All visual information is broadcasted by an intra-retinal pathway formed by a group of neurons called bipolar cells. They collect photorecep...
2015-08-11 - 2019-10-31 | Financiado

BW-KAM2: Innovation Management Capacity Building of SME by the Enterprise Europe Network Baden W rttemberg 2 SMEs are the driving force of economic growth and job creation in Europe: 20.7 million SMEs in the non-financial business economy make up ~9...
2015-06-30 - 2016-12-31 | Financiado

DECIPAIN: An integrated approach towards drug discovery and target validation for pain NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN tramitó un FP7: Chronic and neuropathic pain, usually diagnosed as spontaneous pain, hypersensitivity to pain or both, is a maladaptive response of the orga...
Financiado

NANOSCALE: Understanding interactions between cells and nanopatterned surfaces NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un FP7: The study of biological processes occurring at the nanoscale is becoming a new discipline at the border between Physics and Biology with maj...
Financiado

PREDICT: Predicting individual response and resistance to VEGFR mTOR pathway therapeutic intervention using b... NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un FP7: The strategic development of accurate biomarkers to predict response to therapy in cancer medicine will enhance clinical outcome and reduce...
Financiado

MARCAR: bioMARkers and molecular tumor classification for non genotoxic CARcinogenesis NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un FP7: MARCAR aims to establish reliable early markers and molecular classification of tumors in non genotoxic carcinogenesis, applying a mechanism...
Financiado

STEMBANCC: Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology StemBANCC NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un FP7: StemBANCC, comprising internationally renowned investigators, is ideally positioned to deliver a unique European biorepository and drug disc...
Financiado

NAMASEN: Neuroelectronics and nanotechnology towards a Multidisciplinary Approach for the Science and Engine... NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN participó en un FP7: "We identify Neuroelectronics as a novel mature discipline, at the boundaries between neurobiology, electrophysiology, computational neurosc...
Financiado

NMI